Published in Int Angiol on March 01, 2001
Incidence of venous thromboembolism and its pharmacological prophylaxis in Asian general surgery patients: a systematic review. World J Surg (2015) 1.44
Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol (2004) 1.44
High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer (2007) 1.42
Silent venous thromboembolism before treatment in endometrial cancer and the risk factors. Br J Cancer (2008) 1.08
Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci (2010) 0.99
Foot pumps without graduated compression stockings for prevention of deep-vein thrombosis in total joint replacement: efficacy, safety and patient compliance. A comparative, prospective clinical trial. Int Orthop (2007) 0.99
Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines. J Korean Med Sci (2014) 0.92
Augmentation of venous, arterial and microvascular blood supply in the leg by isometric neuromuscular stimulation via the peroneal nerve. Int J Angiol (2010) 0.87
Comparison of clinical and physiological efficacies of different intermittent sequential pneumatic compression devices in preventing deep vein thrombosis: a prospective randomized study. Clin Orthop Surg (2014) 0.86
Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE. J Zhejiang Univ Sci B (2005) 0.86
Intermittent pneumatic compression for prevention of pulmonary thromboembolism after gynecologic surgery. Thromb J (2005) 0.83
Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery? J Bras Pneumol (2013) 0.82
Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients. Ann Vasc Dis (2015) 0.80
Efficacy and Safety of Enoxaparin for Preventing Venous Thromboembolic Events following Urologic Laparoscopic Surgery. ISRN Urol (2013) 0.78
Primary prevention of venous thromboembolism in elderly medical patients. Clin Interv Aging (2008) 0.78
Fatal pulmonary embolism in hospitalized patients: a large autopsy-based matched case-control study. Clinics (Sao Paulo) (2013) 0.78
Elastic stocking-induced foot necrosis in a patient with severe pneumonia. Ann Vasc Dis (2010) 0.78
An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients. Thromb J (2006) 0.76
Thromboembolic disease after knee arthroplasty is rare in Southern Iran. J Orthop (2014) 0.75
Evidence for treatment of muscular vein thrombosis in orthopaedic patients. J Orthop Traumatol (2013) 0.75
Epidemiological African day for evaluation of patients at risk of venous thrombosis in acute hospital care settings. Cardiovasc J Afr (2014) 0.75
Fondaparınux versus nadroparın for preventıon of venous thromboembolısm after electıve hıp and knee arthroplasty. Curr Ther Res Clin Exp (2013) 0.75
Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry. Br J Clin Pharmacol (2012) 0.75
Efficacy of ankle-brachial index as a preoperative screening in spine surgery. Eur Spine J (2015) 0.75
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. Lancet (1970) 4.48
A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol (2001) 4.39
Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg (2015) 4.18
Genetics of digalactoside-binding adhesin from a uropathogenic Escherichia coli strain. Infect Immun (1983) 4.03
A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol (1973) 3.65
Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (1982) 3.50
Global analysis of the general stress response of Bacillus subtilis. J Bacteriol (2001) 3.45
Molecular cloning and physical characterization of a chromosomal hemolysin from Escherichia coli. Infect Immun (1983) 3.30
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med (1982) 3.16
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med (1979) 2.91
Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke (1999) 2.89
Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg (1970) 2.66
Value of graduated compression stockings in deep venous insufficiency. Br Med J (1980) 2.65
Low doses of heparin in prevention of deep-vein thrombosis. Lancet (1971) 2.38
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Total knee arthroplasty after open reduction and internal fixation of fractures of the tibial plateau: a minimum five-year follow-up study. J Bone Joint Surg Am (2001) 2.34
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res (2001) 2.25
Retroid virus genome replication. Adv Virus Res (1987) 2.23
Graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg (1990) 2.14
The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition. Infect Immun (1990) 2.14
Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet (1972) 2.13
Dynamic microscopy of nanoscale cluster growth at the solid-liquid interface. Nat Mater (2003) 2.07
Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis. N Engl J Med (1981) 2.04
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
The origin of deep vein thrombosis: a venographic study. Br J Radiol (1971) 1.96
A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun (1988) 1.95
Management of abdominal aortic aneurysm. Br J Surg (1978) 1.95
Antithrombotic therapy for venous thromboembolic disease. Chest (2001) 1.94
Model for vesicular stomatitis virus. J Virol (1972) 1.92
Evaluation of non-invasive and invasive methods in the assessment of short saphenous vein termination. Br J Surg (1989) 1.91
Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res (1999) 1.88
Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun (1991) 1.86
Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg (2000) 1.85
Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet (1992) 1.81
Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. J Pharm Sci (1992) 1.80
Characterisation of cauliflower mosaic virus DNA sequences which encode major polyadenylated transcripts. Nucleic Acids Res (1981) 1.77
Replication of cauliflower mosaic virus and transcription of its genome in turnip leaf protoplasts. Virology (1978) 1.76
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Construction and comparison of recombinant plasmids encoding type 1 fimbriae of members of the family Enterobacteriaceae. Infect Immun (1985) 1.70
Recommendations on biosimilar low-molecular-weight heparins. J Thromb Haemost (2009) 1.68
'Real' epidemiology of varicose veins and chronic venous diseases: the San Valentino Vascular Screening Project. Angiology (2002) 1.68
Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J Comp Neurol (1998) 1.67
Antithrombotic therapy for venous thromboembolic disease. Chest (1998) 1.67
Combined use of leg scanning and impedance plethysmography in suspected venous thrombosis. An alternative to venography. N Engl J Med (1977) 1.66
Molecular biology of viral and nonviral retroelements. Trends Genet (1989) 1.65
Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun (1989) 1.65
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ (1991) 1.65
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med (1982) 1.64
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation (2001) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Cellular deformability of the human peripheral blood polymorphonuclear leukocyte: method of study, normal variation and effects of physical and chemical alterations. J Reticuloendothel Soc (1975) 1.60
Multiple forms of genes in pyelonephritogenic Escherichia coli encoding adhesins binding globoseries glycolipid receptors. Infect Immun (1985) 1.58
Influence of adhesins on the interaction of Escherichia coli with human phagocytes. Infect Immun (1984) 1.54
Raynaud's syndrome. BMJ (1990) 1.52
Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg (1979) 1.50
Structure of the cauliflower mosaic virus genome. II. Variation in DNA structure and sequence between isolates. Virology (1978) 1.49
Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am J Pathol (1988) 1.48
Femorodistal vein bypass graft stenoses. Br J Surg (1988) 1.48
A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty. J Invasive Cardiol (2001) 1.48
Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun (1987) 1.45
Cost and effectiveness of laser with phlebectomies compared with foam sclerotherapy in superficial venous insufficiency. Early results of a randomised controlled trial. Eur J Vasc Endovasc Surg (2012) 1.44
Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis. Thromb Haemost (1993) 1.44
Target cell specificity of wild-type E. coli and mutants and clones with genetically defined adhesins. Prog Food Nutr Sci (1983) 1.44
Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost (2006) 1.44
A European view on the North American fifth consensus on antithrombotic therapy. Chest (2000) 1.43
Carotid plaque characterization using digital image processing and its potential in future studies of carotid endarterectomy and angioplasty. J Endovasc Surg (1998) 1.43
Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults. Eur J Endocrinol (1997) 1.43
Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat Biotechnol (2000) 1.43
Haemodynamic significance of incompetent calf perforating veins. Br J Surg (1991) 1.42
Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost (1999) 1.42
Detection and grading of femorodistal vein graft stenoses: duplex velocity measurements compared with angiography. J Vasc Surg (1988) 1.42
Venous thromboembolism--prophylactic and therapeutic practice guideline. S Afr Med J (2009) 1.42
Bacterial adherence--a pathogenetic mechanism in urinary tract infections caused by Escherichia coli. Prog Allergy (1983) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Chromosomal map position of genes encoding P adhesins in uropathogenic Escherichia coli. Infect Immun (1986) 1.40
Laboratory assays for the evaluation of recombinant hirudin. Haemostasis (1991) 1.40
Agoraphobia, back pain and rheumatic diseases. Br J Rheumatol (1989) 1.40
Cardiovascular, autonomic, and plasma catecholamine responses in unilateral and bilateral carotid artery stenosis. J Neurol Neurosurg Psychiatry (1999) 1.40
Benefits of animal research and the doctor's responsibility. BMJ (1990) 1.39
Brain CT infarction in patients with carotid atheroma. Does it predict a future event? Int Angiol (2001) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Maintenance of warfarin therapy at an anticoagulation clinic. S Afr Med J (2007) 1.39
Procedural complications of electroconvulsive therapy: assessment and recommendations. South Med J (1993) 1.39
Histological analysis of the carotid plaque post-endarterectomy: a waste of time or a wasted piece of information? Eur J Vasc Endovasc Surg (2011) 1.39
Validation of a new duplex derived haemodynamic effectiveness score, the saphenous treatment score, in quantifying varicose vein treatments. Eur J Vasc Endovasc Surg (2012) 1.39
Cerebral infarction and familial protein S deficiency. Stroke (1990) 1.39
Rapid aequorin loading into platelets in the presence of DMSO--characteristics of the responses (changes in light transmission and in calcium) to various agonists. Thromb Haemost (1991) 1.38
Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study. Diabetes Care (1998) 1.38
The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol (2000) 1.37
The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin Pharmacol Ther (2013) 1.37
P fimbriae enhance the early establishment of Escherichia coli in the human urinary tract. Mol Microbiol (2000) 1.36
BSR guidelines on standards of care for persons with rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.35
The polarity of the cauliflower mosaic virus genome. Nucleic Acids Res (1979) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol (1995) 1.34
More 'cries from the joints': assessment of the musculoskeletal system is poorly documented in routine paediatric clerking. Rheumatology (Oxford) (2004) 1.34
Myocardial infarction and deep-vein thrombosis. Br Med J (1971) 1.33